Labcorp Launches First FDA-Cleared Blood Test for Alzheimer’s Disease Assessment in Primary Care
Elecsys® pTau-181 test helps clinicians rule out Alzheimer’s disease by identifying patients unlikely to have amyloid pathology Now available nationwide in primary care settings for patients aged 55 and older experiencing symptoms of cognitive decline Expands Labcorp’s comprehensive portfolio of Alzheimer’s disease blood tests across both primary and specialty care settings BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of […]
